Lapatinib, a dual inhibitor of EGFR and HER2, has synergistic effects with 5-fluorouracil on esophageal carcinoma
Xiaofang Guo(Henan Medical University)
Cited by 20
Related Papers
Combination of Berberine with Resveratrol Improves the Lipid-Lowering Efficacy
|International Journal of Molecular Sciences|2018|40
Dual Inhibition of EGFR and IGF-1R Signaling Leads to Enhanced Antitumor Efficacy against Esophageal Squamous Cancer
|International Journal of Molecular Sciences|2022|27